Q32 Bio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $53,737 | $0 |
Gross Profit | -85 | -90 | 53,737 | -91 |
EBITDA | -8,771 | -7,632 | 58,020 | -6,998 |
EBIT | -8,946 | -7,722 | 57,930 | -7,089 |
Net Income | -8,946 | -7,609 | 57,730 | -7,389 |
Net Change In Cash | 0 | 0 | 53,737 | 0 |
Free Cash Flow | -3,075 | -6,343 | -6,180 | -4,230 |
Cash | 106,270 | 50,751 | 48,297 | 49,039 |
Basic Shares | 14,095 | 14,095 | 13,205 | 12,240 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $53,737 | $0 | $-6,651 | $6,651 |
Gross Profit | 53,737 | -487 | -6,651 | 6,651 |
EBITDA | 31,312 | -44,500 | -47,756 | -38,855 |
EBIT | 30,921 | -44,987 | -48,255 | -39,225 |
Net Income | 29,821 | -47,733 | -53,743 | -42,809 |
Net Change In Cash | 53,737 | 0 | -6,651 | 6,651 |
Free Cash Flow | -33,543 | -67,790 | -18,682 | -13,442 |
Cash | 48,297 | 77,965 | 25,617 | 33,986 |
Basic Shares | 12,314 | 9,657 | 11,929 | 11,929 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.44 |
2026-03-31 | -$0.54 |
2025-12-31 | $4.58 |
2025-09-30 | -$0.60 |